The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary results of fruquintinib in combination with FOLFIRI as second-line treatment for RAS-mutant metastatic colorectal cancer: A prospective, single-center phase 2 study.
 
Ru Jia
No Relationships to Disclose
 
Zhi-Kuan Wang
No Relationships to Disclose
 
Quanli Han
No Relationships to Disclose
 
Meng-Jiao Fan
No Relationships to Disclose
 
Nan Zhang
No Relationships to Disclose
 
Guo-Chao Deng
No Relationships to Disclose
 
Fang-Fang Liu
No Relationships to Disclose
 
Yanrong Wang
No Relationships to Disclose
 
Yue Shi
No Relationships to Disclose
 
Yao-Yue Zhang
No Relationships to Disclose
 
Yu-Shan Jia
No Relationships to Disclose
 
Guang-Hai Dai
No Relationships to Disclose